TrialBreast cancer research and treatment2020

N083E (Alliance): long-term outcomes of patients treated in a pilot phase II study of docetaxel, carboplatin, trastuzumab, and lapatinib as adjuvant therapy for early-stage HER2-positive breast cancer.

Roberto A Leon-Ferre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.